Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

A Case Report of a Patient whose Obesity and Diabetes were Induced by Atypical Antipsychotics and Improved by Switching to Amisulpride

Chae JH, Chung YE, Kim W, Bahk WM, Jun TY, Kim KS

  • KMID: 2287292
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):236-240.
Newer atypical antipsychotics have many benefits compared with conventional antipsychotics. However it has been known that atypical antipsychotics are associated with drug-induced weight gain and dibetes mellitus. Obesity and diabetes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy, Safety, and Tolerability of Quetiapine in Patients with Schizophrenia

Kim CH, Kim YK

  • KMID: 2287282
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):135-143.
Atypical antipsychotics have an improved tolerability profile, and are less likely to cause debilitating extrapyramidal symptoms (EPS) than are the conventional antipsychotics. Quetiapine, the fourth atypical antipsychotic, was marketed in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Atypical Antipsychotics: The Benefit and Disadvantage

Kwon JS, Lee KJ

  • KMID: 2287281
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):125-134.
Atypical antipsychotics have more beneficial effects than conventional antipsychotics, particularly with regard to negative symptoms, cognitive functions, and also have a superior side effect profile. Although with such advantages, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quetiapine, Mood Stabilizer?

Bahk WM, Lee KU

  • KMID: 2287284
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):154-161.
As the advantages of atypical antipsychotics in bipolar disorder have been known, the approval of indications of these drugs is expanding. According to APA practice guidelines, in addition to lithium...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Glucose and Cholesterol Level in Schizophrenic Patients Treated with Atypical Antipsychotics or with Valproate Combination

Han DH, Lee JH, Kim TH, Choi JE, Park DB, Kee BS

  • KMID: 2287290
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):211-218.
OBJECTIVE: The association of obesity, diabetes mellitus, drug compliance, and body image with use of antipsychotic medication has been documented in many studies. We aimed to assess the effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Switching Antipsychotic Medications

Kim CY, Park CH

  • KMID: 2287283
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):144-153.
Switch to another newer antipsychotic is indicated when current treatment is insufficiently effective or is associated with drug related adverse events that impair quality of life. There are two main...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antipsychotic Compliance and Maintenance Dosage in Admitted Patients with Schizophrenia Who had been Followed Up Over 6 Months

Kang SH, Kim CY

  • KMID: 2287287
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):186-195.
OBJECTIVE: This study was intended to investigate whether maintenance dosage has been enough for patients with schizophrenia to prevent relapse by examining antipsychotic medication compliance and maintenance dosage during 6...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Associations between Serotonin Transporter Linked Promoter Region Polymorphism and Personality Traits-Normal Female Population Study

Kim SJ, Choi NK, Han CH, Kim CH

  • KMID: 2287289
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):206-210.
OBJECTIVE: The personality traits are substantially heritable, and therefore very likely result from the interplay of genetic variations with environmental influences. Recently, there is a growing enthusiasm for biological approaches...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm for Bipolar Disorder(V): Comparisons with Other Treatment Guidelines

Yoon BH, Jon DI, Shin YC, Min KJ, Kwon JS, Bahk WM

  • KMID: 2287285
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):162-174.
OBJECTIVE: The Korean Medication Algorithm for Bipolar Disorder (KMAP-BP) was developed in 2002 and subsequent minor revisions for mania, bipolar depression and rapid cycling were published recently. To compare the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Serotonin Transporter Polymorphism and the Effect of Atypical Antipsychotics on Serum Glucose and Lipids

Park SH, Kim MC, Yoon SH, Kong BG, Kim YH

  • KMID: 2287288
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):196-205.
OBJECTIVE: The author investigated the association between the genotype distribution of 5-HTTLPR and the effects of atypical antipsychotics on serum glucose and lipids in schizophrenic patients. METHODS: Study subjects were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Questionnaire for Developing the Korean Medication Algorithm for the Treatment of Schizophrenia

Ahn YM, Kwon JS, Kang DY, Kim SH, Kim CY, Bahk WM, Shim JC, An SK, Yi JS, Cho HS, Lee HS, Kim YS

  • KMID: 2287291
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):219-235.
KMAP (Korean Medication Algorithm Project for Major Psychiatric Disorders) was established to develop Korean algorithm for major psychiatric disorders. KMAP developed the draft of Korean medication algorithm for schizophrenia and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Changes in Serum Prolactin Levels after the Administration of Antipsychotics and 5-HT Transporter Polymorphism in Schizophrenic Patients

Seo YS, Ha TM, Park SW, Rhee CG, Park SH, Kim YH

  • KMID: 2287286
  • Korean J Psychopharmacol.
  • 2004 Jun;15(2):175-185.
OBJECTIVE: 1) To compare prolactin responses to (and related clinical manifestations of) haloperidol, risperidone, and other atypical antipsychotics (clozapine, olanzapine, quetiapine, zotepine) with data from previous reports. 2) To investigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr